Upadhye will be replace current CFO MB Chinappa who will take up strategic finance role at Biocon Group and will work with Peter Bains, the...

According to the statement, the ReNew issued bonds worth USD 525 million in 2019, which were set to mature in 2024. By refinancing the doll...

The acquisition is in line with the commitment to enhance the share of renewable power sources in its operation and to comply with regulato...

The third wave has been fuelled by the Omicron variant, which is highly infectious yet milder, causing flu-like symptoms such as fever, bod...

Cipla's branded generics business reported sales of around ₹6,000 crore in FY21. The drug maker's India business, which consists of prescri...

It did well. During the pandemic, it was the responsibility of the industry to do what one can to service. Parallelly, all life-saving medi...

Backorders and complaints over low supply started moderating in the second week of May, the drugmaker said, after it began ramping up produ...

Cipla was among the first companies in India to launch a generic version of remdesivir, developed by U.S.-based Gilead Sciences, and as of ...

Remdesivir was developed by U.S. drugmaker Gilead Sciences Inc, which cut its 2020 revenue forecast last month, citing lower-than-expected ...

Remdesivir, made by U.S.-based Gilead Sciences Inc, has been in high demand globally, and a handful of companies including Cipla are author...

We are in the process of drafting a very robust response to each of the observations in the Form 483.

We are happy with the acceleration of the US pipeline, says Cipla’s Global CFO.

“We are happy with our Q1 numbers in a tough environment.”

The company reported revenues of Rs 15,219 crore, growing 6 per cent, with income from the India operations seeing a 6.3 per cent jump at R...

"We will operate in across the channels and yes we have a good partner and we believe we will get our fair share of the market."

Until recently, Kedar was Vice President, Global Generics Finance and Head of Investor Relations in Dr Reddy's Laboratories, Cipla said in ...

Cipla said in a June 8 announcement to stock exchanges, Kedar Upadhye will be joining the organization as its Global chief financial office...